| |

AWS Target Discovery agent

Byscientist
Element of modern equipment of server providing access to data in control center

AI agents are everywhere accomplishing activities. Drug Discovery agents have been coming on fast and the scale at which these agents approach drug discovery is phenomenal.

There is a great example of a AWS agent that was SPECification built using Kiro from scratch in 3 weeks that delivers drug targets. Amazing to see that it is able to discover new targets using standard BIO databases that they listed:

Literature & Clinical: PubMed, ClinicalTrials.gov, OpenFDA
Drug Discovery: ChEMBL, PubChem, ZINC, GToPdb
Proteins & Genomics: UniProt, STRING, Ensembl, InterPro
Gene Expression: GEO, GTEx, gnomAD, ClinVar, dbSNP
Pathways: Reactome, KEGG, WikiPathways
Structural Biology: PDB, EMDB, AlphaFold
Disease Data: Open Targets, Monarch, GWAS Catalog
Patents: USPTO Patent Search
Specialized: cBioPortal, PRIDE, JASPAR, ReMap, UCSC, and more

Read more about this on the amazon page:

https://aws.amazon.com/blogs/industries/from-spec-to-production-a-three-week-drug-discovery-agent-using-kiro

And then try this out in AWS.

https://github.com/aws-samples/sample-target-identification-agent-using-kiro

Similar Posts

  • Error codes

    Byscientist

    There is no error code in the answers that are provided by AI prompts. It will return an answer that is the best fit to the prompt or the question, but it does not tell you the probability that it is not correct or that it is low probability of answer. The conversational AI will…

  • |

    Alzhiemer’s psychosis

    Byscientist

    Alzheimer’s psychosis is distinct from the slow progression of Alzheimer’s and indicates a more severe phenotype in which cognitive decline starts even before psychosis onset. It is thought to originate/localized in neocortex rather than medial temporal lobe. There is currently only one drug that targets Alzheimer’s psychosis. It is called Rexulti (Brexipipazole). It is specifically…

  • |

    Fitness landscape for antibodies (Flab2)

    Byscientist

    There have been many AI models to predict the structure of proteins, especially antibodies. There are several key aspects to developing antibodies as drugs beyond binding to the target of interest. These are : thermostability, expression, aggregation, binding affinity, pharmacokinetics, polyreactivity and immunogenicity. There have been many models available such as IgLM, ProGen2, Chai-1, ESM2,…

  • |

    Bile duct cancer

    Byscientist

    Bile duct cancer or cholangiocarcinoma, (CCA) is a rare cancer with an incidence of ~3 cases per 100,000 with 10,000 new case diagnosed annually. It is about 10-20% of liver cancers. Interestingly, in Thailand, and some south east asian countries, the incidence is nearly 10 fold higher due to liver fluke infections (Opisthorchis viverrini and…